Evidence map›Paper›PMID 40874186›Full record

ArticleOpen forum infectious diseases2025

Development and Validation of a Machine Learning-Based Screening Algorithm to Predict High-Risk Hepatitis C Infection.

Suk-Chan Jang, Wei-Hsuan Lo-Ciganic, Pilar Hernandez-Con, Chanakan Jenjai, James Huang, Ashley Stultz, Shunhua Yan, Debbie L Wilson, Ashley Norse, Faheem W Guirgis and 7 more

Registry-linked trialAbstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07406490 (Assessing Performance of a Hepatitis C Emergency Department), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07406490 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Assessing Performance of a Hepatitis C Emergency Department (HepC-EnD) Screening Tool: IT Integration Process for Electronic Health Record System

TypeobservationalSponsorUniversity of FloridaRan2026 to 2027Enrolled6,466ConditionsHepatitis C Virus (HCV), Hepatitis C Virus (HCV) Infection, HIV (Human Immunodeficiency Virus)ArmsPhysician-Initiated Screening (Conventional Screening), FOCUS (Universal Screening), HepC-EnD (Targeted Screening)
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Suk-Chan JangCollege of Pharmacy, University of Florida, Gainesville, Florida, USA.ORCID https://orcid.org/0000-0002-6220-7635
Wei-Hsuan Lo-CiganicDepartment of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0001-6590-4770
Pilar Hernandez-ConCollege of Pharmacy, University of Florida, Gainesville, Florida, USA.
Chanakan JenjaiCollege of Pharmacy, University of Florida, Gainesville, Florida, USA.
James HuangCollege of Pharmacy, University of Florida, Gainesville, Florida, USA.
Ashley StultzCollege of Pharmacy, University of Florida, Gainesville, Florida, USA.
Shunhua YanCollege of Pharmacy, University of Florida, Gainesville, Florida, USA.
Debbie L WilsonCollege of Pharmacy, University of Florida, Gainesville, Florida, USA.
Ashley NorseCollege of Medicine, University of Florida, Jacksonville, Florida, USA.
Faheem W GuirgisDepartment of Emergency Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA.
Robert L CookDepartment of Epidemiology, University of Florida, Gainesville, Florida, USA.
Christine GageCollege of Medicine, University of Florida, Jacksonville, Florida, USA.
Khoa A NguyenCollege of Pharmacy, University of Florida, Gainesville, Florida, USA.
Patrick HornesCollege of Medicine, University of Florida, Gainesville, Florida, USA.
Yonghui WuCollege of Medicine, University of Florida, Gainesville, Florida, USA.ORCID https://orcid.org/0000-0002-6780-6135
David R NelsonDepartment of Emergency Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA.
Haesuk ParkCollege of Pharmacy, University of Florida, Gainesville, Florida, USA.ORCID https://orcid.org/0000-0003-3299-8111

Funding

Social determinants of health for predicting risks of HCV infection and HCV/HIV co-infectionR01DA057886 · NIDA · UNIVERSITY OF FLORIDA · PI Haesuk Park · 2023 to 2026
$2.7M
NIDA NIH HHS R01 DA057886
6 · The paper itself

Abstract

Background: Amid the opioid epidemic in the United States, hepatitis C virus (HCV) infections are rising, with one-third of individuals with infection unaware due to the asymptomatic nature. This study aimed to develop and validate a machine learning (ML)-based algorithm to screen individuals at high risk of HCV infection. Methods: We conducted prognostic modeling using the 2016-2023 OneFlorida+ database of all-payer electronic health records. The study included individuals aged ≥18 years who were tested for HCV antibodies, RNA, or genotype. We identified 275 features of HCV, including sociodemographic and clinical characteristics, during a 6-month period before the test result date. Four ML algorithms-elastic net (EN), random forest (RF), gradient boosting machine (GBM), and deep neural network (DNN)-were developed and validated to predict HCV infection. We stratified patients into deciles based on predicted risk. Results: Among 445 624 individuals, 11 823 (2.65%) tested positive for HCV. Training (75%) and validation (25%) samples had similar characteristics (mean, standard deviation age, 45 [16] years; 62.86% female; 54.43% White). The GBM model ( Conclusions: ML algorithms effectively predicted and stratified HCV infection risk, offering a promising targeted screening tool for clinical settings.

Indexed as

HCV infectionhepatitis C virushigh-risk predictionmachine learningscreening algorithm

Identifiers

PMID40874186
PMCPMC12378832

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.